540679 Stock Overview
SMS Lifesciences India Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 1/6 |
SMS Lifesciences India Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹678.25 |
52 Week High | ₹779.00 |
52 Week Low | ₹464.05 |
Beta | 0.66 |
1 Month Change | 7.96% |
3 Month Change | 15.39% |
1 Year Change | 24.70% |
3 Year Change | 11.82% |
5 Year Change | 26.30% |
Change since IPO | 356.43% |
Recent News & Updates
Recent updates
Shareholder Returns
540679 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | -8.0% | -0.1% | 1.8% |
1Y | 24.7% | 55.9% | 46.4% |
Return vs Industry: 540679 underperformed the Indian Pharmaceuticals industry which returned 55.9% over the past year.
Return vs Market: 540679 underperformed the Indian Market which returned 46.4% over the past year.
Price Volatility
540679 volatility | |
---|---|
540679 Average Weekly Movement | 7.8% |
Pharmaceuticals Industry Average Movement | 6.0% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 540679 has not had significant price volatility in the past 3 months.
Volatility Over Time: 540679's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1990 | 567 | Talluri Veera Venkata Murthy | www.smslife.in |
SMS Lifesciences India Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers APIs in various therapeutic areas, such as antiulcer, erectile dysfunction, anti-gout, anesthesia, anti-infective, anti-obesity, antifungal, anti-convulsant, anti-emetic, ophthalmic, anti-worm, and antiemetic. It also exports its products.
SMS Lifesciences India Limited Fundamentals Summary
540679 fundamental statistics | |
---|---|
Market cap | ₹2.04b |
Earnings (TTM) | ₹48.93m |
Revenue (TTM) | ₹2.80b |
41.7x
P/E Ratio0.7x
P/S RatioIs 540679 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
540679 income statement (TTM) | |
---|---|
Revenue | ₹2.80b |
Cost of Revenue | ₹1.95b |
Gross Profit | ₹848.90m |
Other Expenses | ₹799.97m |
Earnings | ₹48.93m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 16.19 |
Gross Margin | 30.35% |
Net Profit Margin | 1.75% |
Debt/Equity Ratio | 58.0% |
How did 540679 perform over the long term?
See historical performance and comparison